Health Care Savings From Lutein, Zeaxanthin Becoming Clear – Study
This article was originally published in The Tan Sheet
Daily intake of 6 to 10 mg of lutein with zeaxanthin by people at risk for age-related macular degeneration could generate $3.6 billion in net health care savings over a five-year period, according to an economic analysis
You may also be interested in...
The Vitamin D and Omega-3 Trial - VITAL - will measure the supplements' preventive effects on cancer, heart disease and stroke in 20,000 participants, making it the largest randomized trial for vitamin D and omega-3 fatty acids. Brigham and Women's Hospital, an affiliate of Harvard Medical School, seeks to enroll women older than 65 and men older than 60 in the five-year study, which will include examinations of how the supplements affect cognitive function, vision disorders and diabetes, the hospital said. BWH Chief of Preventive Medicine JoAnn Manson said June 23 that "these low-cost supplements have the potential of tremendously reducing the burden of chronic disease." Previous economic analysis found omega-3 and vitamin D plus calcium supplementation could save billions in hospitalization costs (1"The Tan Sheet" Sept. 29, 2008, In Brief)
The dietary supplement industry is directly and indirectly responsible for about $61 billion in annual expenditures and more than 450,000 jobs, according to a report on the industry's impact on the U.S. economy
Encouraging seniors to supplement with omega-3 fatty acids and lutein with zeaxanthin could lead to Medicare cost savings of $5.6 bil., according to a Lewin Group study released Nov. 2